drugset / Trial / NCT02080312
Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent
Completed
6 enrolled
University of California, San Diego
American Society of Head and Neck Radiology · collab
NaSingle-groupOpen-labelDiagnostic
Summary
This is a pilot study of patients with clinical symptoms of Ménière's disease using injection of diluted magnetic resonance imaging (MRI) contrast agent into the ear to evaluate inner ear structures. The goal is to reproduce imaging findings described by non-United States (US) institutions, improve on image quality with decreased scan time and evaluate the dynamics of the contrast movement into the inner ear structures.
Timeline
- Start
- 2012-01
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gadopentetate dimeglumine | Diagnostic / imaging agent | 0.4 ml | Other |